PIEZO1 and breast carcinoma: In breast cancer, Li et al. showed that the pharmacological inhibition of PIEZO1 led to the decreased motility of MCF-7 breast cancer cells [26], while Yu et al. reported that PIEZO1 knockdown in MDA-MB-231 breast cancer cells led to increased unconfined cell migration [27].